A new standard of care? Studies on febuxostat in the management of hyperuricemia with and without gout

J Clin Rheumatol. 2011 Jun;17(4 Suppl 2):S11-2. doi: 10.1097/RHU.0b013e31821d479d.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Febuxostat
  • Gout / blood
  • Gout / complications*
  • Gout / drug therapy
  • Gout Suppressants / therapeutic use*
  • Humans
  • Hyperuricemia / blood
  • Hyperuricemia / complications
  • Hyperuricemia / drug therapy*
  • Primary Health Care / standards*
  • Thiazoles / therapeutic use*
  • Treatment Outcome
  • Uric Acid / blood*
  • Xanthine Oxidase / antagonists & inhibitors

Substances

  • Gout Suppressants
  • Thiazoles
  • Febuxostat
  • Uric Acid
  • Xanthine Oxidase